Yüklüyor......
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Introduction: Fifty years after the discovery of Δ(9)-tetrahydrocannabinol (THC) as the psychoactive component of Cannabis, we are assessing the possibility of translating this herb into clinical treatment of inflammatory bowel diseases (IBDs). Here, a discussion on the problems associated with a po...
Kaydedildi:
| Yayımlandı: | Expert Rev Gastroenterol Hepatol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5388177/ https://ncbi.nlm.nih.gov/pubmed/28276820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474124.2017.1292851 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|